While little more patients with no deficient IgA died from respiratory failure (respiratory failure 52.9%; cancer 44.1%), the group with IgA deficiency exhibited a slightly higher proportion of patients who died from cancer (respiratory failure 43.5%; cancer 56.5%). This evidence concerns the gene CD79A and hyperinsulinemic hypoglycemia, familial, 4.